OneVentures-backed artificial heart start-up rattles the tin for $100m

Read the full article: Australian Financial Review

01 April 2025

You may also like

17 April 2026

OneVentures

Meet the women steering Australia’s high-tech future


17 April 2026

Growth Credit

Eucalyptus sells to New York-listed healthcare giant in $1.6b deal


12 January 2026

Healthcare

Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO


View All

Ventured. Gained.
decor